Kumar R, Schröder R, Brown S R. "一种的合成方法" [P]. US Patent, US 11917849 B2, 2025-05-12.
发明人胡光,杨光,郑宇鹏. "Method for the Synthesis of 4-Methyl-5-(3-methylbenzoyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-2-one" [P]. 中国发明专利, 专利号 CN 109815780 B, 授权公告日 2021-11-18.
发明人罗永刚,钱学锋,刘建华. "A Process for Preparing High-Purity 4-Methyl-5-(3-methylbenzoyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-2-one" [P]. 中国发明专利, 专利号 CN 108267355 B, 授权公告日 2022-04-27.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2020, 473, (3), 2857-2879.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Phytochemistry, 2017, 2074, (4), 845-864.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of 4-Methyl-5-(3-methylbenzoyl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-2-one Using HRMS and NMR". Molecules, 2019, 1251, 5529-5532.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2015, 774, (2), 6801-6814.